during the forecast period. The growth in the market is driven by factors such as increasing incidence of burn injuries and increasing number of road accidents and related traumatic wounds. However, high cost of wound care biological products and risks associated with skin substitute failure are the major factors hindering the growth of this market.
NEW YORK, June 22, 2022 (Globe Newswire) — Reportlinker.com Announces the Release of Report “Wound Care Biologics Market by Product, Wound Type, End User – Global Forecast to 2027” –
The organic skin substitute segment accounted for the highest growth rate in the wound care biologics market, by product, during the forecast period
The wound care biologics market is segmented into organic skin substitutes and topical agents. The organic skin option is expected to register the highest growth rate during the forecast period.
Factors such as increasing burden of surgical and traumatic wounds and increase in burn injuries are contributing to the growth of this segment.
Highest CAGR in Hospitals segment
On the basis of end users, the wound care biologics market has been segmented into hospitals, ambulatory surgery centers, and burn care centers, and wound clinics. The hospital segment is expected to register the highest CAGR during the forecast period.
Prolonged hospital stays or re-admissions of patients with chronic conditions have increased the adoption of various wound care biological products. The increasing incidence of hospital-acquired wounds is a major growth driver for this market segment.
Furthermore, adoption of wound care biological products in hospitals is high due to their high purchasing power, highly skilled health care professionals and access to technologically advanced surgical facilities.
Asia Pacific market is expected to grow at the highest CAGR during the forecast period
The global wound care biologics market is segmented into five regions – North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to witness the highest growth in the wound care biologics market. forecast period.
The high growth in this sector is mainly attributed to the increasing prevalence of diabetes, rising expenditure on health care, increase in per capita income, expansion of private sector hospitals in rural areas in various APAC countries, increase in medical tourism and presence of high can be held responsible. -Development market. The low labor cost and favorable regulatory environment in this sector is also expected to boost the market growth.
The preliminary interviews conducted for this report can be classified as follows:
• By company type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 -30%
• By designation: C-Level – 27%, D-Level – 18%, and Others – 55%
• By region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East and Africa – 4%
List of companies included in the report:
• Smith & Nephew Plc (UK)
• Organogenesis Inc. (America)
• MIMEDX (USA)
• Integra Lifesciences (US)
• Stryker Corporation (USA)
• Molnlike Health Care AB (Sweden)
• Verisel Corporation (US)
• Bioventus LLC (US)
• Anika Therapeutics, Inc. (America)
• AbbVie Inc. (America)
• Kéresis (Iceland)
• Marine Polymer Technologies, Inc. (US)
• Merakris Therapeutics (USA)
• Polymedics Innovation GmbH (Germany)
• FibrohealWoundcare Pvt. Ltd. (India)
• Anamay Biotech, Inc. (India)
• Vircho Biotech Private Limited (India)
• Medline Industries, LP (America)
• Tides Medical (in the US)
• Viscus Biologics LLC (US)
• Sustainability Biology (USA)
• MTF Biologics (US)
Sky Biologics Holdings, LLC (US)
• Allosource (US)
• Surgilogics (USA)
This report provides a comprehensive picture of the global Wound Care Biologics market. The objective is to estimate the market size and future growth potential across various segments such as product, wound type, end user and region.
The report also includes an in-depth competitive analysis of the major market players along with their company profiles, recent developments and key market strategies.
Key benefits of buying reports:
The report will help market leaders/new entrants by providing the closest estimates of revenue numbers for the overall Wound Care Biologics market and its subsegments. It will also help the stakeholders to better understand the competitive landscape and gain more insights to better position their business. and create appropriate go-to-market strategies. The report will enable the stakeholders to understand the pulse of the market and provide them with information on key market drivers, restrictions and opportunities.
Read full report:
ReportLinker is an award winning market research solution. ReportLinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
Contact: Claire: [email protected] US: (339) -368-6001 International: +1 339-368-6001